food-thumbnail.png

Beta-Glucan Market Research Report – Segmented By Type (Cereal Beta-Glucan, Yeast Beta-Glucan, Mushroom Beta-Glucan, Seaweed Beta-Glucan); By Distribution Channel (Direct Sales, Retail Stores, Online Channels, Specialty Stores, Pharmacies); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Beta-Glucan Market Size (2024 – 2030)

The Beta-Glucan Market ​ was valued at USD 421.6 Million in 2024 and is projected to reach a market size of USD 685.91 Million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 7.2%.

BETA-GLUCAN MARKET

Beta-glucan has emerged as a crucial bioactive compound in the health and wellness industry, gaining significant traction across pharmaceutical, food and beverage, and cosmetic applications. This naturally occurring polysaccharide, found primarily in cereal grains, certain types of mushrooms, and yeast, has captured substantial market attention due to its immune-boosting properties and diverse health benefits. The market has witnessed remarkable growth driven by increasing consumer awareness about preventive healthcare and the rising demand for natural ingredients in functional foods. The industry has experienced significant transformation, with manufacturers focusing on innovative extraction techniques and product formulations to meet the growing demand across various end-use sectors. The market has shown particular strength in dietary supplements and functional foods, where beta-glucan is increasingly being incorporated as a key ingredient for its cholesterol-lowering properties and immune system enhancement capabilities. Recent developments in processing technologies have enabled better extraction efficiency and product quality, leading to expanded applications in premium skincare products and pharmaceutical formulations. The market has also benefited from the growing trend toward clean-label products and natural ingredients, positioning beta-glucan as a preferred choice for manufacturers looking to meet consumer demands for healthier alternatives.

Key Market Insights:

  • Beta-glucan extracted from oats made up 42% of the total market share in terms of raw material used.

  • The global cosmetics industry used approximately 8,700 metric tons of beta-glucan in 2023 for skincare products.

  • The pet food industry consumed nearly 11,000 metric tons of beta-glucan in 2023, focusing on immune-boosting pet supplements.

  • Beta-glucan derived from yeast saw an increase in demand, with 28% of the total market share by product type.

  • The global beta-glucan market in 2023 saw a 16% increase in research and development expenditure compared to the previous year.

  • Over 2,300 new beta-glucan-enriched food products were launched worldwide in 2023.

  • The use of beta-glucan in pharmaceuticals reached an estimated market size of $250 million in 2023.

  • More than 19% of functional foods and beverages launched in 2023 included beta-glucan as a key ingredient for immune support.

  • The average price of beta-glucan used in the food industry was around $40 per kilogram in 2023.

  • Beta-glucan’s role in cholesterol-lowering supplements accounted for 46% of the market revenue in the nutraceuticals sector in 2023.

  • Approximately 7,800 clinical studies related to beta-glucan were active or completed in 2023.

  • Beta-glucan’s application in anti-aging skincare formulations grew by 23% in 2023 compared to the previous year.

  • Around 15% of beta-glucan production in 2023 was allocated to cancer treatment adjunct therapies.

  • The global consumption of beta-glucan in sports nutrition products reached 5,200 metric tons in 2023.

  • In 2023, more than 65% of beta-glucan manufacturers focused on sustainability certifications to attract health-conscious consumers.

  • The use of beta-glucan in infant formula products increased by 18% in 2023, driven by rising awareness of its immune-boosting properties.

Beta-Glucan Market ​Drivers:

The increasing global focus on preventive healthcare and immune system enhancement has emerged as a primary driver for the beta-glucan market.

In recent years, consumers have become increasingly proactive about their health, seeking natural solutions to boost their immune systems and maintain overall wellness. Beta-glucan's scientifically proven immunomodulatory properties have positioned it as a key ingredient in this health-conscious landscape. The compound's ability to activate macrophages and enhance the body's natural defence mechanisms has garnered significant attention from both consumers and healthcare professionals. This has led to increased incorporation of beta-glucan in various health supplements and functional foods. The rising awareness about the link between gut health and immune function has further accelerated the demand, as beta-glucan acts as a prebiotic fiber that supports beneficial gut bacteria. The healthcare industry's endorsement of beta-glucan's benefits has strengthened consumer trust, leading to higher adoption rates in daily dietary supplements. Clinical studies supporting its efficacy in reducing the risk of respiratory infections and improving post-exercise recovery have contributed to its popularity among athletes and fitness enthusiasts. The compound's natural origin aligns perfectly with the growing preference for clean-label products, making it an attractive option for manufacturers looking to meet consumer demands for natural health solutions.

The functional food and beverage industry has emerged as a significant driver for the beta-glucan market, with manufacturers increasingly incorporating this ingredient into various product formulations.

The versatility of beta-glucan as a functional ingredient has opened up numerous opportunities for product innovation and market expansion. Its ability to improve the nutritional profile of foods while simultaneously enhancing texture and stability has made it a valuable ingredient in product development. Food manufacturers have successfully integrated beta-glucan into a wide range of products, including breakfast cereals, bakery items, dairy products, and beverages, capitalizing on its dual functionality as both a health-promoting ingredient and a natural food stabilizer. The growing demand for products with specific health claims, particularly those related to heart health and blood sugar management, has driven the incorporation of beta-glucan into everyday food items. Its status as a FDA-approved ingredient for cholesterol-reduction claims has provided manufacturers with a significant marketing advantage. The rising popularity of plant-based diets has further boosted demand, as beta-glucan offers an excellent way to enhance the nutritional value of plant-based products while mai

Beta-Glucan Market Restraints and Challenges:

The beta-glucan market faces several significant challenges and restraints that impact its growth trajectory. One of the primary challenges lies in the complex and costly extraction processes required to obtain high-quality beta-glucan. The technical expertise and sophisticated equipment needed for efficient extraction contribute to higher production costs, ultimately affecting product pricing and market accessibility. Another significant challenge is the variability in product quality and standardization. Different sources of beta-glucan (yeast, cereals, mushrooms) yield products with varying molecular weights and biological activities, making it difficult to maintain consistent product quality across applications. This variability can impact the efficacy of final products and create challenges in meeting regulatory requirements. The market also faces challenges related to consumer education and awareness. Despite growing recognition of beta-glucan's benefits, many consumers remain unfamiliar with the ingredient and its advantages. This knowledge gap can limit market penetration, particularly in emerging economies where awareness of functional ingredients is still developing. Supply chain vulnerabilities represent another significant challenge. The availability of raw materials can be affected by agricultural conditions, climate changes, and geopolitical factors. These supply chain disruptions can lead to price fluctuations and impact product availability. Regulatory compliance presents ongoing challenges, particularly in different geographic regions with varying standards and requirements. Manufacturers must navigate complex regulatory landscapes while ensuring their products meet all necessary safety and quality standards. The cost of regulatory compliance and certification can be substantial, particularly for smaller players in the market. Technical limitations in product formulation also pose challenges. Beta-glucan's incorporation into certain food matrices can affect texture, taste, and stability, requiring significant research and development efforts to overcome these limitations. This can extend product development timelines and increase costs.

Beta-Glucan Market Opportunities:

The beta-glucan market presents numerous compelling opportunities for growth and innovation. One of the most promising opportunities lies in the development of novel delivery systems and formulations that enhance the bioavailability and effectiveness of beta-glucan. Advanced encapsulation technologies and nano-delivery systems offer potential for improved product performance and expanded applications. The growing demand for personalized nutrition presents another significant opportunity. Beta-glucan's versatility allows for customization based on specific health needs and consumer preferences, opening doors for targeted product development in the personalized nutrition sector. This can lead to the creation of specialized formulations for different demographic groups and health conditions. The cosmetics and personal care industry offers substantial growth potential for beta-glucan applications. Its natural moisturizing and anti-aging properties align well with the clean beauty trend, creating opportunities for innovative skincare formulations and beauty supplements. The increasing consumer preference for natural and sustainable beauty products further enhances this opportunity. Technological advancements in extraction and processing methods present opportunities for cost optimization and quality improvement. Investment in research and development of more efficient production processes could lead to better yield rates and reduced production costs, making beta-glucan more accessible to a broader market. The emerging markets in developing countries represent untapped potential for market expansion. Rising disposable incomes, growing health awareness, and increasing demand for functional foods in these regions create opportunities for market penetration and growth. The development of locally adapted products and marketing strategies could help capture these emerging market opportunities. The pet food and animal nutrition sector presents another avenue for growth, with increasing demand for functional ingredients in animal feed and pet care products. Beta-glucan's immune-boosting properties make it an attractive ingredient for premium pet food formulations and animal health supplements.

BETA-GLUCAN MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2023 - 2030

Base Year

2023

Forecast Period

2024 - 2030

CAGR

7.2%

Segments Covered

By Type,  Distribution Channel and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

Kerry Group, Lesaffre Group, Royal DSM, Biotec Pharmacon ASA, Lallemand Inc., Tate & Lyle PLC, Associated British Foods PLC, Biothera Pharmaceuticals Inc., Super Beta Glucan Inc., Garuda International Inc., Leiber GmbH, Ceapro Inc., Angel Yeast Co. Ltd., Specialty Biotech Co., Ltd.

Beta-Glucan Market Segmentation: By Types

  • Cereal Beta-Glucan

  • Yeast Beta-Glucan

  • Mushroom Beta-Glucan

  • Seaweed Beta-Glucan

Yeast Beta-Glucan dominates the market with a 48% share due to its high purity levels and established manufacturing processes. The strong presence in pharmaceutical and supplement applications has maintained its market leadership.

Mushroom Beta-Glucan is experiencing the highest growth rate due to increasing recognition of its unique immunomodulatory properties and growing consumer interest in mushroom-based products.

Beta-Glucan Market Segmentation: By Distribution Channel

  • Direct Sales

  • Retail Stores

  • Online Channels

  • Specialty Stores

  • Pharmacies

Direct Sales leads with 42% market share, primarily driven by bulk purchases from pharmaceutical and food manufacturing companies.

Online Channels are showing the highest growth rate, benefiting from increasing e-commerce adoption and direct-to-consumer trends.

 

Beta-Glucan Market Segmentation: Regional Analysis

  • North America

  • Europe

  • Asia-Pacific

  • Latin America

  • Middle East and Africa

North America maintains market dominance due to advanced healthcare infrastructure, high consumer awareness, and the strong presence of major manufacturers. The region's leadership in research and development, coupled with high healthcare spending, has established its market supremacy.

Asia Pacific shows the highest growth rate, driven by rapid urbanization, increasing health consciousness, and rising disposable incomes. The region's large population base and growing middle class present significant growth opportunities. Countries like China and India are becoming major markets for beta-glucan products, particularly in functional foods and supplements.

COVID-19 Impact Analysis on the Beta-Glucan Market ​:

The pandemic heightened consumer awareness about immune health, leading to increased interest in beta-glucan products. This resulted in accelerated market growth, particularly in the supplements sector. Manufacturers responded by ramping up production of immune health products containing beta-glucan, while also implementing new safety protocols in their facilities. E-commerce channels emerged as crucial distribution platforms during lockdown periods, leading to significant growth in online sales of beta-glucan products. This shift in consumer purchasing behaviour has had lasting effects on market dynamics, with many companies strengthening their digital presence and direct-to-consumer capabilities. The pharmaceutical sector saw increased research activity investigating beta-glucan's potential role in supporting immune function against viral infections. This has led to new research partnerships and increased investment in clinical studies, potentially expanding future applications. Manufacturing facilities adapted to new safety protocols and automated processes, leading to improved operational efficiency.

Latest Trends/ Developments:

Personalization has emerged as a key trend, with companies developing targeted formulations for specific demographic groups and health conditions. This includes specialized products for athletes, elderly consumers, and individuals with specific health concerns. Sustainability has become a crucial focus, with manufacturers implementing eco-friendly production processes and sustainable sourcing practices. This includes the development of waste-reduction strategies and the use of renewable energy in production facilities. Digital transformation is revolutionizing market dynamics, with companies leveraging artificial intelligence and blockchain technology for supply chain management and quality control. This has improved traceability and transparency in the production process. Product innovation continues to drive market growth, with new applications emerging in areas such as sports nutrition, beauty supplements, and pet care products. Companies are also exploring novel delivery formats, including gummies, powdered drinks, and functional snacks. Clean label and natural formulations remain priority areas, with manufacturers focusing on minimal processing and transparent ingredient sourcing. This aligns with growing consumer demand for natural, clean-label products.

Key Players:

  1. Kerry Group

  2. Lesaffre Group

  3. Royal DSM

  4. Biotec Pharmacon ASA

  5. Lallemand Inc.

  6. Tate & Lyle PLC

  7. Associated British Foods PLC

  8. Biothera Pharmaceuticals Inc.

  9. Super Beta Glucan Inc.

  10. Garuda International Inc.

  11. Leiber GmbH

  12. Ceapro Inc.

  13. Angel Yeast Co. Ltd.

  14. Specialty Biotech Co., Ltd.

Chapter 1. Beta-Glucan Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Beta-Glucan Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
                 2.2.1    Demand Side
                 2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Beta-Glucan Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Beta-Glucan Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
                 4.5.1    Bargaining Power of Suppliers
                 4.5.2    Bargaining Powers of Customers
                 4.5.3    Threat of New Entrants
                 4.5.4    Rivalry among Existing Players
                 4.5.5    Threat of Substitutes 
Chapter 5. Beta-Glucan Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Beta-Glucan Market – By Types
6.1    Introduction/Key Findings   
6.2    Cereal Beta-Glucan
6.3    Yeast Beta-Glucan
6.4    Mushroom Beta-Glucan
6.5    Seaweed Beta-Glucan
6.6    Y-O-Y Growth trend Analysis By Types
6.7    Absolute $ Opportunity Analysis By Types, 2024-2030 
Chapter 7. Beta-Glucan Market – By Distribution Channel
7.1    Introduction/Key Findings   
7.2    Direct Sales
7.3    Retail Stores
7.4    Online Channels
7.5    Specialty Stores
7.6    Pharmacies
7.7    Y-O-Y Growth  trend Analysis By Distribution Channel
7.8    Absolute $ Opportunity Analysis By Distribution Channel, 2024-2030  
Chapter 8. Beta-Glucan Market , By Geography – Market Size, Forecast, Trends & Insights
8.1    North America
                 8.1.1    By Country
                                  8.1.1.1    U.S.A.
                                  8.1.1.2    Canada
                                  8.1.1.3    Mexico
                 8.1.2    By Types
                 8.1.3    By Distribution Channel
                 8.1.4    Countries & Segments - Market Attractiveness Analysis
8.2    Europe
                 8.2.1    By Country
                                  8.2.1.1    U.K
                                  8.2.1.2    Germany
                                  8.2.1.3    France
                                  8.2.1.4    Italy
                                  8.2.1.5    Spain
                                  8.2.1.6    Rest of Europe
                 8.2.2    By Types
                 8.2.3    By Distribution Channel
                 8.2.4    Countries & Segments - Market Attractiveness Analysis
8.3    Asia Pacific
                 8.3.1    By Country
                                  8.3.1.1    China
                                  8.3.1.2    Japan
                                  8.3.1.3    South Korea
                                  8.3.1.4    India      
                                  8.3.1.5    Australia & New Zealand
                                  8.3.1.6    Rest of Asia-Pacific
                 8.3.2    By Types
                 8.3.3    By Distribution Channel
                 8.3.4    Countries & Segments - Market Attractiveness Analysis
8.4    South America
                 8.4.1    By Country
                                  8.4.1.1    Brazil
                                  8.4.1.2    Argentina
                                  8.4.1.3    Colombia
                                  8.4.1.4    Chile
                                  8.4.1.5    Rest of South America
                 8.4.2    By Types
                 8.4.3    By Distribution Channel
                 8.4.4    Countries & Segments - Market Attractiveness Analysis
8.5    Middle East & Africa
                 8.5.1    By Country
                                  8.5.1.1    United Arab Emirates (UAE)
                                  8.5.1.2    Saudi Arabia
                                  8.5.1.3    Qatar
                                  8.5.1.4    Israel
                                  8.5.1.5    South Africa
                                  8.5.1.6    Nigeria
                                  8.5.1.7    Kenya
                                  8.5.1.8    Egypt
                                  8.5.1.9    Rest of MEA
                 8.5.2    By Types
                 8.5.3    By Distribution Channel
                 8.5.4    Countries & Segments - Market Attractiveness Analysis 
Chapter 9. Beta-Glucan Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1    Kerry Group
9.2    Lesaffre Group
9.3    Royal DSM
9.4    Biotec Pharmacon ASA
9.5    Lallemand Inc.
9.6    Tate & Lyle PLC
9.7    Associated British Foods PLC
9.8    Biothera Pharmaceuticals Inc.
9.9    Super Beta Glucan Inc.
9.10    Garuda International Inc.
9.11    Leiber GmbH
9.12    Ceapro Inc.
9.13    Angel Yeast Co. Ltd.
9.14    Specialty Biotech Co., Ltd.

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

Beta-glucans are recognized for their potential health benefits, including improved immune function, cholesterol reduction, and blood sugar control.

Obtaining regulatory approval for specific health claims associated with beta-glucans can be challenging, especially in different regions.

Kerry Group leads the market with significant investments in research and development, followed closely by Lesaffre Group and Royal DSM. Biotec Pharmacon ASA and Lallemand Inc. have made substantial contributions to market growth through their focus on pharmaceutical applications. Tate & Lyle PLC, Associated British Foods PLC, and Biothera Pharmaceuticals Inc. maintain strong positions through their diverse product portfolios.

North America is the most dominant region in the market, accounting for approximately 35% of the total market share.

Asia Pacific is the fastest-growing region in the market.

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.